Increasing awareness of recognition of chronic obstructive pulmonary disease

Chinese Medical Journal

Volumn 119, Issue 8, 2006, Pages 669-675

  Wang, Zeng Li ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Chronic obstructive pulmonary disease; Guideline; Management; Underecognition

Indexed keywords

ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CILOMILAST; CORTICOSTEROID; FORMOTEROL; LONG ACTING DRUG; OXYGEN; PLACEBO; SALMETEROL; THEOPHYLLINE; TIOTROPIN; UNCLASSIFIED DRUG;

ARTICLE; ARTIFICIAL VENTILATION; ASTHMA; AWARENESS; BACTERIAL INFECTION; CHINA; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG MEGADOSE; DYSPNEA; EMPHYSEMA; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOSTIMULATION; INCIDENCE; MORBIDITY; MORTALITY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PREVALENCE; PULMONARY HYPERTENSION; SPIROMETRY; SURVIVAL RATE; WORLD HEALTH ORGANIZATION; REVIEW;

HUMANS; PATIENT COMPLIANCE; PRACTICE GUIDELINES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SURVIVAL RATE;

EID: 33646825794     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200604020-00008     Document Type: Article

References (31)

1. Sullivan SD, Buist AS, Weiss K. Health outcomes assessment and economic evaluation in COPD: challenges and opportunities. Eur Respir J 2003; 21 Suppl 41: 1S-3S.
2. Ran PX, Liu SM, Zhou YM, Zheng JP, Lu JC, Wang C, et al. Prevalence of chronic obstructive pulmonary disease (COPD) in China. 10th Congress of the APSR. Guangzhou, China. 2005.
3. Hurd S. The impact of COPD on lung health worldwide, epidemiology and incidence. Chest 2000; 117 (2 Suppl): 1S-4S.
4. Connolly CK. Chronic obstructive pulmonary disease: underdiagnosed, underinvestigated, inappropriately managed? Eur Respir J 2003; 21:556-560.
5. Wouters EF. Economic analysis of the confronting COPD survey: an overview of results. Respir Med 2003; 97 Suppl C: S3-S14.
6. Oga T, Nashimura K, Tsukimo, M, Sato S, Hajiro T. Analysis of the factors to mortality in chronic obstructive pulmonary disease; role of exercise capacity and health status. Am J Respir Crit Care Mad 2003; 167: 544-549.
7. Sutherland ER, Cherniack MD. Management of chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 2689-2697.
8. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Workshop report. 2004.
9. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Mad 1995;152: S77-S121.
10. Zhao MW. Two points concerning the prevention and management of chronic obstructive pulmonary disease. Chin J Tuberc Respir Dis (Chin) 2001; 24: 577-578.
11. Fishman AP. One hundred years of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171:941-948.
12. Vestbo J, Lange P. Can GOLD stage O provide information of prognosis value in COPD? Am J Respir Crit Care Med 2002; 166:329-332.
13. Weiss ST, DeMeo DL, Postma DS. COPD: problems in diagnosis and measurement. Eur Respir J 2003; 41: 4S-12S.
14. Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med 2000; 343:269-279.
15. Wilkinson TM, Donaldson GC, Hurst JR, Seemangel TA, Wedzicha JA. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 169:1298-1303.
16. White AJ, Gompertz S, Stockley RA. Chronic obstructive pulmonary disease. 6: the aetiology of exacerbations of chronic obstructive pulmonary disease. Thorax 2003; 58:73-80.
17. Miravitlles M, Ferrer M, Pont A, Zalacain R, Alvarez-Sala JL. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease: a 2 years follow up study. Thorax 2004;59:389-395.
18. Emtner M, Porszasz J, Burns M, Somfay A, Casaburi R. Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients. Am J Rospir Crit Care Med 2003; 168:1034-1042.
19. Wouters EF. Management of severe COPD. Lancet 2004; 364: 883-895.
20. 2-agonists and corticosteroids in stable COPD. Chest 2004; 126: 220-237.
21. Tashkin DP, Cooper CB. The role of long-acting bronchodilators in the management of stable COPD. Chest 2004;125:249-259.
22. Cazzola M, Matera MG. Long-acting bronchodilators are the first-choice option for the treatment of stable COPD. Chest 2004;125:9-11.
23. Hanania NA, Darken P, Horstman D, Reismer C, Lee B, Davis S. The efficacy and safety of fluticasone propionate (250 μg)/ Salmeterol (50 μg) combined in the diskus inhaler for the treatment of COPD. Chest 2003; 124:834-843.
24. Fan VS, Bryson CL, Curtis JR Fihn SD, Bridevaux PD, McDonell MB, et al. Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death and hospitalization. Am J Respir Crit Care Med 2003;168:1488-1494.
25. Sin DD, Lacy P, York E, Man SF. Effects of fluticasone on systemic marker of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;170:760-765.
26. Remmard SI, Schachter N, Strek M, Richard K, Amit O. Cilomilast for COPD results of a 6-month, placebo, controlled study of a potent, selective inhibator of phosohodiesterase 4. Chest 2006;129:56-66.
27. Chailleux E, Laaban JP, Veale D. Prognostic value of nutritional depletion in patients with COPD treated by long-term oxygen therapy data from ANTADIR observatory. Chest 2003;123:1460-1466.
28. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. On behalf of the GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global inititive for GOLD workshop summary. Am J Respir Crit Care Med 2001;163;1256-1276.
29. Plant PK, Elliott MW. Chronic obstructive pulmorary disease 9: management of ventilatory failure in COPD. Thorax 2003;58:537-542.
30. Collaborating Research Group for Noninvasive Mechanical Ventilation of Chinese Respiratory Society. Pulmonary infection control window in treatment of severe respiratory failure of chronic obstructive pulmonary disease: a prospective, randomized controlled, multi-centred study. Chin Med J 2005; 118:1589-1594.
31. Jindal SK. Immnostimulation does it work in COPD? Chest 2004; 126:1406-1407.